Menú

ISAC
ISAC (Intervencions Sanitàries i Activitats Comunitàries)

RESPONSABLE DEL GRUP
avatar_investigadors.jpg
Francisco Martín Luján
fmartin.tgn.ics@gencat.cat
avatar_grups_recerca.png

Publicacions

Immunocompromised Status Definition in Observational Studies Using Electronic Health Records: A Scoping Review and a Proposal for a Phenotype Identification Algorithm.

Riera-Arnau J, Luxi N, Riefolo F, Solorzano M, Pazos I, Ballarín E, Svingel LS, Chiusaroli L, Martín-Merino E, Barbieri E, Lopez-Lasanta M, Mohammadi S, Rotta D, Pacurariu A, Cohet C, Sturkenboom M and Durán CE
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2026 Apr 1; . doi:10.1002/pds.70362; PMID:41902365

Veure més:
Effect of combined aerobic and resistance training on kidney health in adults with type 2 diabetes: A randomized controlled trial.

Burton O, Díaz-López A, Villalobos F, Pedret R and Arija V
Diabetes & Metabolic Syndrome-Clinical Research & Reviews. 2026 Mar 24; . doi:10.1016/j.dsx.2026.103404; PMID:41886945

Veure més:
Harmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU Experience.

Dehghan Tarazjani A, Weibel D, Aurelius T, Zwiers LC, Van den Berg JM, Pérez-Breva L, Gimeno-Miguel A, Stona L, Solórzano M, Desalegn AA, Poblador-Plou B, Lysen TS, Wheler J, Zidan M, Carreras JJ, Villalobos F, Ehrenstein V, Morton K, Rebordosa C, Ahmadizar F, Fortuny J, Arana A and Sturkenboom M
Clinical Epidemiology. 2026 Jan 30; . doi:10.2147/CLEP.S558974; PMID:41890771

Veure més:
Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant women.

Maisonneuve E, Luxi N, Bellitto C, Ciccimarra F, Raethke M, van Hunsel F, Lieber T, Mulder E, Riefolo F, Villalobos F, Thurin NH, Batel-Marques F, Morton K, O'Shaughnessy F, Cleary B, Sonderlichová S, Farcas A, Bucsa C, Favre G, Siiskonen SJ, Baud D, Sturkenboom MCJM, Trifirò G and Panchaud A
Frontiers In Drug Safety And Regulation. 2025 Dec 29; . doi:10.3389/fdsfr.2025.1689349; PMID:41532034

Veure més:
Flares of Ten Autoimmune Diseases: Clinical Definitions, Operational Algorithms, and Background Incidence Rates in Seven European Electronic Healthcare Data Sources

M. SOLÓRZANO, F. RIEFOLO, R. GINI, D. MESSINA, G. ROBERTO, I. PAZOS, N. LUXI, J. RIERA-ARNAU, S. MOHAMMADI, A. VILASECA, K. MORTON, E. BARBIERI, G. STURNIOLO, L. CHIUSAROLI, M. RIVEIRO-BARCIELA, M. DAVIES, C. ZAFON, O. VIAPIANA, D. ROTTA, N. BORRUEL, S. DHANDA, D. ROY, Y. INGRASCIOTTA, M. CAROLLO, A. ERRA, M. LOPEZ-LASANTA, M. ROSSINI, C. BELLITTO, F. VILLALOBOS, H. NORDENG, M. ZIDAN, B. CASTILLO-CANO, E. MARTÍN-MERINO, J. CARRERAS, A. FORNES, P. SOUVEREIN, J. JOVÉ, M. BERNARD, M. STURKENBOOM and C. DURÁN
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2026 Mar 13;

Veure més:

Patronat

Col·laboradors

Acreditacions